| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 151, Issue 4 2050-2061, Copyright © 1993 by American Association of Immunologists
ARTICLES |
E Prina, C Jouanne, S de Souza Lao, A Szabo, JG Guillet and JC Antoine
Unite d'Immunophysiologie Cellulaire, Institut Pasteur, Paris, France.
Leishmania-infected M phi are potential candidates for the presentation of parasite Ag to Leishmania-specific CD4+ T lymphocytes. To assess whether infected cells could function as APC, we examined the ability of bone marrow-derived M phi infected with Leishmania amazonensis amastigotes to stimulate various CD4+, l-Ad- or l-Ed-restricted T-cell hybridomas specific for the bacteriophage lambda repressor cl protein, the human chorionic gonadotropin or OVA. A reduced capacity of infected M phi to present native Ag to most T-cell hybridomas tested was noted that was probably a result of a lower expression on their plasma membrane of stimulatory [la-peptide] complexes. Neither a reduced Ag uptake nor an altered Ag processing appeared to be at the origin of the partial inability of infected M phi to present Ag. As regards the level of plasma membrane la expression, no quantitative difference could be detected between uninfected and infected M phi. Moreover, after fixation with paraformaldehyde, the ability of plasma membrane la molecules to bind immunogenic peptides was apparently not reduced in infected M phi. So, these cells most likely expressed functional la molecules on their cell surface. Interestingly, infected M phi and M phi infected then cured by a treatment with a leishmanicidal compound were similarly impaired in their capacity to present native Ag or peptides to the hybridomas, and no recovery was noted even 24 h after the leishmanicidal treatment. Furthermore, infected M phi and M phi incubated with heat-killed amastigotes or with an amastigote homogenate exhibited similar inhibitions of Ag presentation. Taken together, these results suggest that the functional failure of infected M phi to present exogenous Ag could be because either of interferences with the events leading to the meeting of la molecules with peptides derived from these exogenous Ag or to a competition for binding to la molecules between these peptides and parasite molecules.
This article has been cited by other articles:
|
|
 |
|
  P. Barrionuevo, J. Cassataro, M. V. Delpino, A. Zwerdling, K. A. Pasquevich, C. G. Samartino, J. C. Wallach, C. A. Fossati, and G. H. Giambartolomei Brucella abortus Inhibits Major Histocompatibility Complex Class II Expression and Antigen Processing through Interleukin-6 Secretion via Toll-Like Receptor 2 Infect. Immun., January 1, 2008; 76(1): 250 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chakraborty, S. Banerjee, A. Sen, K. K. Banerjee, P. Das, and S. Roy Leishmania donovani Affects Antigen Presentation of Macrophage by Disrupting Lipid Rafts J. Immunol., September 1, 2005; 175(5): 3214 - 3224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Olivier, D. J. Gregory, and G. Forget Subversion Mechanisms by Which Leishmania Parasites Can Escape the Host Immune Response: a Signaling Point of View Clin. Microbiol. Rev., April 1, 2005; 18(2): 293 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. F. Vanloubbeeck, A. E. Ramer, F. Jie, and D. E. Jones CD4+ Th1 Cells Induced by Dendritic Cell-Based Immunotherapy in Mice Chronically Infected with Leishmania amazonensis Do Not Promote Healing Infect. Immun., August 1, 2004; 72(8): 4455 - 4463. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Meier, M. Svensson, and P. M. Kaye Leishmania-Induced Inhibition of Macrophage Antigen Presentation Analyzed at the Single-Cell Level J. Immunol., December 15, 2003; 171(12): 6706 - 6713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Qi, V. Popov, and L. Soong Leishmania amazonensis-Dendritic Cell Interactions In Vitro and the Priming of Parasite-Specific CD4+ T Cells In Vivo J. Immunol., October 15, 2001; 167(8): 4534 - 4542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. B. Kremer, M. P. Gould, K. D. Cooper, and F. P. Heinzel Pretreatment with Recombinant Flt3 Ligand Partially Protects against Progressive Cutaneous Leishmaniasis in Susceptible BALB/c Mice Infect. Immun., February 1, 2001; 69(2): 673 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Forestier, F. Deleuil, N. Lapaque, E. Moreno, and J.-P. Gorvel Brucella abortus Lipopolysaccharide in Murine Peritoneal Macrophages Acts as a Down-Regulator of T Cell Activation J. Immunol., November 1, 2000; 165(9): 5202 - 5210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Belkaid, S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. Sacks A Natural Model of Leishmania major Infection Reveals a Prolonged ""Silent"" Phase of Parasite Amplification in the Skin Before the Onset of Lesion Formation and Immunity J. Immunol., July 15, 2000; 165(2): 969 - 977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Jones, L. U. Buxbaum, and P. Scott IL-4-Independent Inhibition of IL-12 Responsiveness During Leishmania amazonensis Infection J. Immunol., July 1, 2000; 165(1): 364 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Soussi, G. Milon, J.-H. Colle, E. Mougneau, N. Glaichenhaus, and P. L. Goossens Listeria monocytogenes as a Short-Lived Delivery System for the Induction of Type 1 Cell-Mediated Immunity against the p36/LACK Antigen of Leishmania major Infect. Immun., March 1, 2000; 68(3): 1498 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Alexander, A. Satoskar, and D. Russell Leishmania species: models of intracellular parasitism J. Cell Sci., January 9, 1999; 112(18): 2993 - 3002. [Abstract] [PDF]
|
|
|
|
|
|
J. Antoine, T Lang, E Prina, N Courret, and R Hellio H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leishmania-infected macrophages and internalized by amastigotes of L. amazonensis and L. mexicana J. Cell Sci., January 8, 1999; 112(15): 2559 - 2570. [Abstract] [PDF]
|
|
|
|
|
|
E. Pinelli, V. P. M. G. Rutten, M. Bruysters, P. F. Moore, and E. J. Ruitenberg Compensation for Decreased Expression of B7 Molecules on Leishmania infantum-Infected Canine Macrophages Results in Restoration of Parasite-Specific T-Cell Proliferation and Gamma Interferon Production Infect. Immun., January 1, 1999; 67(1): 237 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schwarzer, M. Alessio, D. Ulliers, and P. Arese Phagocytosis of the Malarial Pigment, Hemozoin, Impairs Expression of Major Histocompatibility Complex Class II Antigen, CD54, and CD11c in Human Monocytes Infect. Immun., April 1, 1998; 66(4): 1601 - 1606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Brown, K. Swier, N. H. Moskowitz, M. F. Naujokas, R. M. Locksley, and S. L. Reiner T Helper Subset Differentiation in the Absence of Invariant Chain J. Exp. Med., January 6, 1997; 185(1): 31 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S De Souza Leao, T Lang, E Prina, R Hellio, and J. Antoine Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells J. Cell Sci., January 10, 1995; 108(10): 3219 - 3231. [Abstract] [PDF]
|
|
|
|
|
|
T Lang, R Hellio, P. Kaye, and J. Antoine Leishmania donovani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation J. Cell Sci., January 8, 1994; 107(8): 2137 - 2150. [Abstract] [PDF]
|
|
|
|
|
|
T Lang, C de Chastellier, C Frehel, R Hellio, P Metezeau, S. Leao, and J. Antoine Distribution of MHC class I and of MHC class II molecules in macrophages infected with Leishmania amazonensis J. Cell Sci., January 1, 1994; 107(1): 69 - 82. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
